Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
-
Published:2021-04
Issue:
Volume:897
Page:173928
-
ISSN:0014-2999
-
Container-title:European Journal of Pharmacology
-
language:en
-
Short-container-title:European Journal of Pharmacology
Author:
Sharma Pawan,McAlinden Kielan D.,Ghavami Saeid,Deshpande Deepak A.
Funder
National Institutes of Health
Reference72 articles.
1. Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study;Abd-Elsalam;Am. J. Trop. Med. Hyg.,2020 2. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice;Barnard;Antivir. Chem. Chemother.,2006 3. Hydroxychloroquine: from malaria to autoimmunity;Ben-Zvi;Clin. Rev. Allergy Immunol.,2012 4. Cavalcanti, A.B., Zampieri, F.G., Rosa, R.G., Azevedo, L.C.P., Veiga, V.C., Avezum, A., Damiani, L.P., Marcadenti, A., Kawano-Dourado, L., Lisboa, T., Junqueira, D.L.M., de Barros, E.S.P.G.M., Tramujas, L., Abreu-Silva, E.O., Laranjeira, L.N., Soares, A.T., Echenique, L.S., Pereira, A.J., Freitas, F.G.R., Gebara, O.C.E., Dantas, V.C.S., Furtado, R.H.M., Milan, E.P., Golin, N.A., Cardoso, F.F., Maia, I.S., Hoffmann Filho, C.R., Kormann, A.P.M., Amazonas, R.B., Bocchi de Oliveira, M.F., Serpa-Neto, A., Falavigna, M., Lopes, R.D., Machado, F.R., Berwanger, O., Coalition covid-19 Brazil, I.I., 2020. Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19. N. Engl. J. Med. 383, 2041-2052. 5. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma;Charous;Ann. Allergy,1990
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|